期刊文献+

血管活性药物在心力衰竭治疗中的应用 被引量:1

Vasoactive drugs in treatment of heart failure
在线阅读 下载PDF
导出
摘要 1 概述 急性心力衰竭常危及生命, 我国部分医院调查,急性心力衰竭占住院心血管病患者的16.3%~17.9%,心力衰竭病因主要为冠心病、入院时心功能都以Ⅲ级居多。基本为慢性心力衰竭的急性加重。急性左心力衰竭患者需紧急和积极治疗,本文参考我国急性心力衰竭指南介绍血管活性药物的应用规范。
作者 朱文玲
出处 《中国医学前沿杂志(电子版)》 2010年第1期16-19,共4页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
  • 相关文献

参考文献8

  • 1谢洪智,朱文玲.重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究[J].中华心血管病杂志,2006,34(3):222-226. 被引量:228
  • 2Nieminen MS,Bohm M,Cowie MR,et al.Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. European Heart Journal . 2005
  • 3Follath F,Cleland JG,Just H,et al.Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet,The . 2002
  • 4Moiseyev VS,Poder P,Andrejevs N,et al.Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). European Heart Journal . 2002
  • 5Hunt SA,Abraham WT,Chin MH,et al.2009 focused update incorporatedinto the ACC/AHA 2005 Guidelines for the Diagnosis and Management ofHeart Failure in Adults:a report of the American College of Cardiology Foun-dation/American Heart Association Task Force on Practice Guidelines:devel-oped. Circulation . 2009
  • 6Yancy CW,Singh A.Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insufficiency (from the Follow-Up Serial Infusions of Nesiritide [FUSION I] trial). The American Journal of Cardiology . 2006
  • 7Cuffe MS,Califf RM,Adams KF Jr,et al.For the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure(OPTIME-CHF)investigations Short-term intravenous milrinone for acute exacerbation of chronic heart failure:a randomized controlled trial. Journal of the American Medical Association, The . 2002
  • 8Yancy CW,Krum H,Massie BM,et al.The second followup serial infusionsof nesiritide(FUSIONⅡ)trial for advanced heart failure:study rationale anddesign. American Heart Journal . 2007

二级参考文献9

  • 1Abraham WT,Lowes BD,Ferguson DA,et al.Systemic hemodynamic,neurohormonal,and renal excretory effects of a steady-state infusion of human brain natriuretic peptide in patients with decompensated chronic heart failure.J Card Fail,1998,4:37-44.
  • 2Mills RM,LeJemtel TH,Horton DP,et al.Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure:a randomized,double-blind,placebo-controlled clinical trial.Natrecor Study Group.J Am Coll Cardiol,1999,34:155-162.
  • 3Colucci WS,Elkayam E,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated heart failure.N Engl J Med,2000,343:246-253.
  • 4Kawakami R,Saito Y,Kishimoto I,et al.Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction.Circulation,2004,110:3306-3312.
  • 5Keating GM,Goa KL.Nesiritide:a review of its use in acute decompensated heart failure.Drugs,2003,63:47-70.
  • 6de Lemos JA,McGuire DK,Drazner MH.B-type natriuretic peptide in cardiovascular disease.Lancet,2003,362:316-322.
  • 7Strain WD.The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.Int J Clin Pract,2004,58:1081-1087.
  • 8de Denus S,Pharand C,Williamson DR.Brain natriuretic peptide in the management of heart failure:the versatile neurohormone.Chest,2004,125:652-668.
  • 9Colucci WS.Nesiritide for the treatment of decompensated heart failure.J Card Fail,2001,7:92-100.

共引文献227

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部